Cardiovascutar risk factors and homocysteine in epitepsy

被引:39
作者
Elliotta, John O.
Jacobson, Mercedes P.
Haneef, Zulfi
机构
[1] Ohio State Univ, Dept Neurol, Columbus, OH 43210 USA
[2] Temple Univ, Sch Med, Dept Neurol, Philadelphia, PA 19140 USA
关键词
epilepsy; cardiovascular risk; factors; framingham risk; score; homocysteine;
D O I
10.1016/j.eplepsyres.2007.07.005
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Epidemiological studies have found the risk for heart disease and stroke are increased in persons with epilepsy. Anti-epileptic drugs (AEDs) have varying effects on serum Lipids and homocysteine-an independent risk factor for coronary disease. The prevalence of cardiovascular risk factors (high cholesterol, hypertension, diabetes, obesity and smoking) and homocysteine were investigated in a multiethnic epilepsy population. Data included demographics, clinical factors, tab assessments and supplementation patterns. Mean age was 45 years (71 males and 94 females)-75 were African American, 27 Latina and 60 Caucasian. Fifty-two percent of participants had two or more cardiovascular risk factors when compared with rates for the general population of 28%. The Framingham risk score (FRS) assessment was also used to compare risk levels. Twenty-nine percent of men and 1% of women had a FRS indicating >5% level of risk, only 7% had a FRS > 10%. Cardiovascular screening and primary preventative recommendations based on the American Heart Association and supplementation should be suggested for the adult epilepsy population when appropriate. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:113 / 123
页数:11
相关论文
共 68 条
[1]   Thyroid function during B-vitamin supplementation of patients on antiepileptic drugs [J].
Apeland, T ;
Kristensen, O ;
Strandjord, RE ;
Mansoor, MA .
CLINICAL BIOCHEMISTRY, 2006, 39 (03) :282-286
[2]   Fasting and post-methionine loading concentrations of homocysteine, vitamin B2, and vitamin B4, in patients on antiepileptic drugs [J].
Apeland, T ;
Mansoor, MA ;
Pentieva, K ;
McNulty, H ;
Strandjord, RE .
CLINICAL CHEMISTRY, 2003, 49 (06) :1005-1008
[3]   Antiepileptic drugs as independent predictors of plasma total homocysteine levels [J].
Apeland, T ;
Mansoor, MA ;
Strandjord, RE .
EPILEPSY RESEARCH, 2001, 47 (1-2) :27-35
[4]   Homocysteine concentrations and methionine loading in patients on antiepileptic drugs [J].
Apeland, T ;
Mansoor, MA ;
Strandjord, RE ;
Kristensen, O .
ACTA NEUROLOGICA SCANDINAVICA, 2000, 101 (04) :217-223
[5]   Twenty-year trends in serum cholesterol, hypercholesterolemia, and cholesterol medication use - The Minnesota Heart Survey, 1980-1982 to 2000-2002 [J].
Arnett, DK ;
Jacobs, DR ;
Luepker, RV ;
Blackburn, H ;
Armstrong, C ;
Claas, SA .
CIRCULATION, 2005, 112 (25) :3884-3891
[6]   Early effect of sodium valproate and carbamazepine monotherapy on homocysteine metabolism in children with epilepsy [J].
Attilakos, Achilleas ;
Papakonstantinou, Evangellos ;
Schulpis, Kleopatra ;
Voudris, Konstantinos ;
Katsarou, Eustathia ;
Mastroyianni, Sotiria ;
Garoufi, Anastasia .
EPILEPSY RESEARCH, 2006, 71 (2-3) :229-232
[7]  
Booth GL, 2000, CAN MED ASSOC J, V163, P21
[8]   Lipoprotein(a) concentration increases during treatment with carbamazepine [J].
Brämswig, S ;
Sudhop, T ;
Luers, C ;
von Bergmann, K ;
Berthold, HK .
EPILEPSIA, 2003, 44 (03) :457-460
[9]   Carbamazepine increases atherogenic lipoproteins:: mechanism of action in male adults [J].
Brämswig, S ;
Kerksiek, A ;
Sudhop, T ;
Luers, C ;
Von Bergmann, K ;
Berthold, HK .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2002, 282 (02) :H704-H716
[10]   Comparison of current guidelines for primary prevention of coronary heart disease - Risk assessment and lipid-lowering therapy [J].
Broedl, UC ;
Geiss, HC ;
Parhofer, KG .
JOURNAL OF GENERAL INTERNAL MEDICINE, 2003, 18 (03) :190-195